Edward Tenthoff

Ted Tenthoff is a managing director and senior research analyst at Piper Sandler, focused on the drug discovery sector of the biotech industry. In April 2013 and 2015, Tenthoff moderated panels at the International Adult Stem Cell Conference at the Vatican. He was ranked No. 2 stock picker in biotechnology by the 2012 Wall Street Journal "Best on the Street" survey and was ranked No. 1 stock picker for the life science tools and services sector in the 2006 Starmine Analyst Awards. Prior to joining Piper Sandler in 2003, he covered the genomics sector at Robertson Stephens & Company, and was a medical technology analyst at Lehman Brothers. Tenthoff received a bachelor’s degree in international relations from the University of Pennsylvania.

Universe Coverage

Biotechnology
ALNY	Alnylam Pharmaceuticals, Inc.
ARWR	Arrowhead Pharmaceuticals
ARVN	Arvinas Inc.
CAPR	Capricor Therapeutics, Inc.
IPSC	Century Therapeutics, Inc.
CRSP	CRISPR Therapeutics AG
CUE	Cue Biopharma, Inc.
DYN	Dyne Therapeutics, Inc.
FATE	Fate Therapeutics, Inc.
FULC	Fulcrum Therapeutics, Inc.
KRON	Kronos Bio, Inc.
KYMR	Kymera Therapeutics, Inc.
LEGN	Legend Biotech Corporation
MESO	Mesoblast Ltd.
MIST	Milestone Pharmaceuticals, Inc.
MRNA	Moderna, Inc.
GLUE	Monte Rosa Therapeutics, Inc.
NXTC	NextCure, Inc.
OMGA	Omega Therapeutics, Inc.
OPK	OPKO Health, Inc.
PSTX	Poseida Therapeutics, Inc.
RAPT	Rapt Therapeutics, Inc.
MCRB	Seres Therapeutics, Inc.
SKYE	Skye Bioscience, Inc.
STRO	Sutro Biopharma, Inc.
SYRS	Syros Pharmaceuticals, Inc.
TPST	Tempest Therapeutics, Inc.
XFOR	X4 Pharmaceuticals, Inc.
XNCR	Xencor, Inc.